BackgroundBlood biomarkers of Alzheimer's disease (AD) may allow for the early detection
of AD pathology in mild cognitive impairment (MCI) due to AD (MCI-AD) and as a co …

It is estimated that between 50% and 75% of all cases of dementia are due to Alzheimer's
disease (AD), the most common neurodegenerative disease among World population …

Guarana (Paullinia cupana) is a plant from the Amazon region with cultural importance.
Despite its early ancestral use by indigenous tribes, the first reports regarding the benefits of …

Objective To determine whether mild cognitive impairment with Lewy bodies or mild
cognitive impairment with Alzheimer disease differ in their rates of clinical progression to …

Objective: The present study aimed to clarify the neuropsychological profile of the emergent
diagnostic category of Mild Cognitive Impairment with Lewy bodies (MCI-LB) and determine …

Background Alzheimer's disease (AD) co‐pathology is common in dementia with Lewy
bodies and is associated with increased decline. Plasma pTau181 is a blood‐based …

Background Given the complex and progressive nature of mild cognitive impairment (MCI),
the ability to delineate and understand the heterogeneous cognitive trajectories is crucial for …

Socially inappropriate behavior accompanies and modulates delinquency across the
lifespan. In contrast to young people, the emergence of such traits among older individuals …

Background Predicting which individuals may convert to dementia from mild cognitive
impairment (MCI) remains difficult in clinical practice. Electroencephalography (EEG) is a …

Introduction Dementia and physical disability are serious problems faced by the aging
population, and their occurrence and development interact. Methods Based on data from a …